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Nutrient deficiencies and excess are involved in many aspects of human health. As a source of essential nutrients, eggs have been
used worldwide to support the nutritional needs of human societies. On the other hand, eggs also contain a significant amount
of cholesterol, a lipid molecule that has been associated with the development of cardiovascular diseases. Whether the increase
of egg consumption will lead to elevated cholesterol absorption and disruption of cholesterol homeostasis has been a concern
of debate for a while. Cholesterol homeostasis is regulated through its dietary intake, endogenous biosynthesis, utilization, and
excretion. Recently, some research interests have been paid to the effects of egg consumption on cholesterol homeostasis through
the intestinal cholesterol absorption. Nutrient components in eggs such as phospholipids may contribute to this process. The goals
of this review are to summarize the recent progress in this area and to discuss some potential benefits of egg consumption.

1. Introduction
A homeostatic cholesterol regulation system exists in the
human body. The loss of cholesterol homeostasis results in
abnormal cholesterol metabolism such as hypercholesterolemia, which is associated with the development of cardiovascular diseases (CVD) including atherosclerosis, coronary
heart disease, and stroke. CVD is one of the leading causes of
death globally, which resulted in 17.9 million deaths (32.1%)
in 2015 and was increased from 12.3 million (25.8%) in
1990 [1]. According to results of epidemiology studies, high
plasma cholesterol level, especially high level of low-density
lipoprotein (LDL), is directly associated with CVD, while the
leve of high-density lipoprotein (HDL) is negatively related
to CVD risk [2]. The relationship between blood cholesterol
and heart disease was firstly confirmed by the Framingham
Heart Study [3], and the hypothesis that dietary cholesterol
is also associated with heart diseases was proposed [4]. The
hypothesis was supported by animal study in rabbits in 1913
[5] and observational studies in 1980s [6, 7], demonstrating a
link between dietary cholesterol and risk of heart diseases.
In 1968, the American Heart Association (AHA) recommended that the dietary cholesterol consumption should be

no more than 300 mg/day and emphasized no more than 3
egg yolks should be consumed per week [8]. The average
intake of dietary cholesterol in US adults ranges from 200
to 350 mg/day due to sex and age differences [9]. Daily
intake of eggs and egg products in US children and adults
accounts for 25% of daily total cholesterol intake [10, 11].
Some researchers recommended that food which is rich in
cholesterol, such as eggs, should be limited in an attempt
to lower the plasma cholesterol level [3]. A series of “low
cholesterol” and “cholesterol free” food advertised on media.
The “evil” of cholesterol and eggs has been announced to
publics constantly, which still exists nowadays.
The following studies showed contradictory results.
Shekelle (1989) and Kushi (1985) found dietary cholesterol
was correlated to CVD risks, but they failed to take many
confounding variables into account, such as genes, hormones,
other dietary components, lifestyle, and the nutritional status
of the subjects [6, 7]. On the other hand, later epidemiological studies and systematic reviews reported a marginal
correlation between dietary cholesterol and/or egg intake
and CVD incidence in the general population [12–23]. With
increasing evidences of weak correlation, AHA eliminated
the restriction of egg consumption in 2002 and the dietary
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Figure 1: The structure of egg yolk lipoprotein. The outer layer of egg yolk lipoprotein is mainly composed of phospholipids, with free
cholesterol scattered and integral and peripheral apolipoprotein attached. The hydrophobic triacylglycerol and cholesteryl ester exist in core.

restriction of cholesterol for healthy population in 2013 [24].
Furthermore the US Dietary Guidelines Advisory Committee
(DGAC) also eliminated this restriction from the latest
version of dietary guideline in 2015 [25].
After being debated for half a century, dietary cholesterol
and egg intake finally got rid of the nature of “evil.” Moreover,
recent studies reported that multiple bioactive components
in eggs have potential benefits to overall health through
the lifespan, such as supplying micronutrients, antioxidants,
antimicrobials, and reducing risk of cancer and hypertension
[26]. This brings the nutrient value of eggs back to a hot spot.
This review aims to summarize recent research progress on
the composition and nutritional value of egg components,
cholesterol homeostasis, the relationship between dietary egg
intake and blood cholesterol, and the effects of different egg
components.

2. Composition and Nutritional Value of
Egg Components
Eggs, an inexpensive but highly nutritious food, provide
balanced nutrients that impact human health [25, 26]. Eggs
contain ample essential proteins, fats, vitamins, minerals,
and bioactive compounds, and their compositions and net
amount could be influenced by strain, age, hen diet, and
environmental conditions. The nutrients to energy density
ratio of one egg is high with many essential nutrients as shown
in Table 1 [27]. A medium-sized boiled egg (50 g) contains
78 kcal energy, 6.29 g protein, 0.56 g carbohydrate, and 5.3 g
total fat, of which 1.6 g is saturated, 2.0 g is monounsaturated,
0.7g is polyunsaturated, and 186 mg is cholesterol. As for
micronutrients, egg contains a variety of minerals (calcium,
iron, magnesium, phosphorus, potassium, sodium, and Zinc)
and most vitamins (thiamin, riboflavin, niacin, vitamin B6 ,
folate, vitamin B12 , vitamin A, vitamin E, vitamin D, and
vitamin K) except for vitamin C. Some of these nutrients,

such as zinc, vitamin A, vitamin D, and vitamin E, may not
be enough in a western diet.
2.1. Egg Proteins. For humans, eggs are one of the best sources
of high quality protein, only inferior to breast milk. Egg
proteins have been proved to possess antioxidants, such as
phosvitin which contains large amount of phosphoserines,
ovotransferrin that can chelate with Fe3+ , and ovalbumin
that can covalently bind to polysaccharide to enhance its
antioxidant activity [28, 29]. These proteins can inhibit lipid
oxidation by binding to metal or scavenging free radical. Eggs
may be used as a potential natural source of antioxidant,
which can be further used in food or cosmetics industry.
The antioxidant function of eggs could prevent humans from
a large number of degenerative processes, such as CVD
occurring [30]. Besides, egg protein, especially egg yolk
protein, has a significantly greater satiety effect compared
with other protein sources [31, 32]. Some research results
have shown that there was reduced energy intake after the
breakfast with an egg and a bagel [33], larger weight loss after
8 weeks with the breakfast containing an egg and a bagel
as part of a hypocaloric diet [34], and significant change in
satiety hormones after an egg in the breakfast [35]. Proteins
in egg yolk can be classified into apolipoproteins, phosvitin,
egg yolk globulin, and riboflavin binding protein [36].
2.2. Egg Lipoproteins. Egg lipoproteins include LDL and
HDL. The LDL in the yolk accounts for about 2/3 of the dry
matter of the egg yolk which can be divided into the soluble
part and whey part [37]. The density of LDL is 0.982 g/ml.
LDL particles are spherical and the average diameter is
between 35 and 40 nm. As shown in Figure 1, the core of the
particles is made of triglycerides (TG) and cholesterol esters
(CE) that are surrounded by apolipoproteins, phospholipids,
and cholesterol [38]. Montserret et al. demonstrated that LDL
can disperse at the oil-water interface, with phospholipids
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Table 1: Nutrient values of a medium-size boiled egg, whole milk with added vitamin D, and boiled manufacturing beefa .
Category
Nutrient

Unit

Boiled egg
1 large
1Value
(50.0 g)
(100 g)

Whole milk with added vitamin D
1Value
(100 g)

Boiled manufacturing beef
1Value
(100 g)

Proximates
Energy

kcal

78

155

61

126

Water

g

37.31

74.62

88.13

73.1

Protein

g

6.29

12.58

3.15

24.21

Total lipid (fat)

g

5.3

10.61

3.25

3.26

Carbohydrate, by difference

g

0.56

1.12

4.8

0

Fiber, total dietary

g

0

0

0

0

Sugars, total

g

0.56

1.12

5.05

0

Calcium, Ca

mg

25

50

113

6

Iron, Fe

mg

0.59

1.19

0.03

1.78

Magnesium, Mg

mg

5

10

10

16

Phosphorus, P

mg

86

172

84

129

Minerals

Potassium, K

mg

63

126

132

183

Sodium, Na

mg

62

124

43

32

Zinc, Zn

mg

0.53

1.05

0.37

5.02

Vitamins
Vitamin C, total ascorbic acid

mg

0

0

0

0

Thiamin

mg

0.033

0.066

0.046

0.042

Riboflavin

mg

0.257

0.513

0.169

0.096

Niacin

mg

0.032

0.064

0.089

1.759

Vitamin B6

mg

0.06

0.121

0.036

0.16

Folate, DFE

𝜇g

22

44

5

0

Vitamin B12

𝜇g

0.56

1.11

0.45

1.02

Vitamin A, RAE

𝜇g

74

149

46

8

Vitamin A, IU

IU

260

520

162

27

Vitamin E (𝛼-tocopherol)

mg

0.52

1.03

0.07

0.57

Vitamin D (D2 + D3 )

𝜇g

1.1

2.2

1.3

0.1

Vitamin D

IU

44

87

51

5

Vitamin K (phylloquinone)

𝜇g

0.1

0.3

0.3

0

g

1.633

3.267

1.865

1.154

Lipids
SFAsb
b

MUFAs

g

2.038

4.077

0.812

0.897

PUFAsb

g

0.707

1.414

0.195

0.246

Trans fatty acids

g

0

0

0

0.078

mg

186

373

10

67

Cholesterol
a

Nutrient values and weights are for edible portion; b SFAs: saturated fatty acids, MUFAs: monounsaturated fatty acids, and PUFAs: polyunsaturated fatty acids.

and apolipoproteins attached to the surface of the nucleus,
and the central core combines with oil droplets [39]. There
are six major apolipoproteins: A, B, C, D, E, and H [38].
Apolipoprotein with molecular weight of 15 kDa is the most
active form on the surface of microparticles. Apolipoproteins
contain higher proportion of amphipathic 𝛼-helices after

extraction. Therefore, apolipoproteins can be adsorbed effectively at the oil-water interface [38]. More than 95% of the
yolk cholesterol are stored in LDL, more than 90% of which
present in free (nonesterified) form [40]. Free cholesterol
plays an important role in maintaining the structure of
lipoproteins. They are packed between adjacent phospholipid
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molecules to maintain the stability of the oil/water interface
[40]. Almost 98% of sterols in the egg yolk are cholesterol, the
rest of which are a small amount of phytosterols such as betasitosterol, methyl cholestereol, and sorbitol mycotoxins [41].
2.3. Egg Lipids. In addition to protein, eggs also contain a
large number of active lipid components, such as unsaturated fatty acids, phospholipids, choline, and carotenoids. As
shown in Table 1, monounsaturated fatty acids (MUFAs) and
polyunsaturated fatty acids (PUFAs) are, respectively, 2.0 g
and 0.7 g, and content of saturated fatty acids is 1.6 g in one
medium-size egg. Phospholipids account for approximately
10% of the wet weight of egg yolk [42], which mainly includes
phosphatidylcholine (PC), phosphatidylethanolamine (PE),
lysophosphatidylcholine (lysoPC), sphingomyelin (SM), and
some neutral lipids in minor quantities. Dietary phospholipids, a potential source of bioactive lipids, may have
broad effects on cholesterol metabolism, HDL functions, and
inflammation [43]. Yang et al. reported that dietary PUFAs,
PC, and SM significantly inhibit the uptake of cholesterol
in Caco-2 monolayer, which may have potential therapeutic
effect on reducing cholesterol absorption as functional food
ingredients [44, 45]. As a component of lecithin, choline
also exists in egg in a larger amount [46]. Choline may
play a particularly useful role in fetal and neonatal brain
development, as inadequate choline intake during pregnancy
increases neural tube defects risk of infant [47, 48]. Other
functional components from egg are the carotenoids, which
are natural pigments in hen egg yolks and account for less
than 1% of yolk lipids [28, 49]. The two major carotenoids
in eggs are carotene and xanthophylls (lutein, cryptoxanthin,
and zeaxanthin) which are highly bioavailable in egg yolk
and are associated with the reduced risk of age-related macular degeneration and cataracts, cancer, and carotid artery
atherosclerosis [28, 49, 50].

3. Regulation of Cholesterol Absorption
Cholesterol homeostasis depends mainly on the balance
among cholesterol absorption in the intestine, endogenous
cholesterol synthesis, and utilization for the synthesis of
bile acids and steroids. High blood cholesterol level is an
important risk factor for CVD. Therefore, a large number
of studies focused on investigating the key genetic, physicochemical, and biochemical indicators of intestinal cholesterol
absorption in the small intestine.
3.1. Physiological Process of Cholesterol in the Small Intestine.
There are three sources of cholesterol in the small intestine:
diet, bile, and shedding of intestinal epithelial cells [51]. The
daily cholesterol intake in a typical Western diet is about 300500 mg/day. Bile contributes to 800-1200 mg of cholesterol
per day in the small intestine lumen [51]. Although the
entire small intestine can absorb cholesterol, the main sites
of absorption are the duodenum and the proximal jejunum.
TGs are hydrolyzed by pancreatic lipase, phospholipids
are hydrolyzed by pancreatic phospholipase, and CEs are
hydrolyzed by carboxylester lipase. The digestive products
are monoacylglycerides, small amount of diacylglycerols,
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lysophospholipids, free cholesterol, and free fatty acids. These
products can form micelles with bile acids, cross the unstirred
water layer on the side of the brush boarder, and absorbed
into enterocytes by passive diffusing or mediated transporting [51]. Hydrophilic bile acids can reduce the absorption of
cholesterol in the small intestine by decreasing the solubility
of cholesterol on the out-shell of micelles [52]. Compared to
the cholesterol, sterol and plant phytosterols are easier to be
incorporated into micelles, which leads to the reduction of
cholesterol absorption efficiency in the small intestine [52]. In
the enterocytes, TGs, CEs, and phospholipids are generated
again and packed into chylomicrons for distribution in the
lymphatic circulation and then the blood [51]. Upon the
hydrolysis by lipoprotein lipase, chylomicrons eventually
become chylomicron remnants, which are taken into the liver.
The lipids in chylomicron remnants are reassembled into
very-low-density lipoproteins [51].
Cholesterol is specifically absorbed by Niemann-Pick C1Like 1 (NPC1L1), which is a newly discovered transporter,
and excreted by ATP-binding cassette (ABC) G member
5 (G5) and G8, which can also speed up the absorption
of cholesterol, on the apical side of small intestine epithelium membrane [53]. Ezetimibe reduces the absorption of
cholesterol in the small intestine by inhibiting the activity of
NPC1L1 protein [52]. Nearly half of cholesterol molecules are
transported to the endoplasmic reticulum (ER) after entering
the epithelium and reesterified into CEs by Acyl-coenzyme
A:cholesterol acyltransferases (ACAT) [53]. These CEs are
transported to the Golgi apparatus and then loaded unto
chylomicrons via microsomal triglyceride transfer protein
(MTP). Free cholesterol also participates in forming the shell
of chylomicron precursors [53]. Part of cholesterol and bile
acids can escape the absorption in the small intestine and
are excreted in the stool as neutral sterols and acidic sterols,
which is the major elimination route of sterols from the
body [52]. The exact molecular mechanisms of intestinal
cholesterol absorption are still under investigation.
3.2. Factors Affecting the Efficiency of Intestinal Cholesterol Absorption. The cholesterol absorption efficiency varies
among animal species and human subjects. Table 2 summarizes the key factors affecting cholesterol absorption
including dietary factors, pharmacological influence, bile
acid factors, genetic factors, and intestinal lumen factors.
Intestinal absorption efficiency can also be affected by the
factors that influence cholesterol transport from the small
intestine to the lymphatic system. Changes in these factors
can help to explain the differences in the absorption efficiency
of cholesterol in the small intestine within individuals and
species.
Fang et al. evaluated the effects of six fatty acids, palmitic
acid, oleic acid, linoleic acid, arachidonic acid, eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA), on
cholesterol uptake and transport in human enterocytes Caco2 cells and on the expression levels of NPC1L1 and others proteins involved in cholesterol absorption. The results showed
that EPA and DHA dose-dependently inhibited cholesterol
uptake and transport in Caco-2 monolayer, which might be
caused by downregulating NPC1L1 level [45].
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Table 2: Possible factors influencing intestinal cholesterol absorptiona,b .
Influencingc

Research method

References

(-)

Mouse feeding studies

Duan 2004 [64]

↑ Stearic Acid

↓

Rat feeding studies

Kelley 1978 [65];
Vahouny 1988 [66]

↑ MUFAs

↓

↑ 𝜔-3 PUFAs

↓

African green monkey feeding studies
African green monkey feeding studies
Caco-2 cells

Johnson 1985 [67]
Johnson 1985 [67]
Fang 2018 [44]

↑ Fish Oil

↓

Rat feeding studies

Chen 1987 [68]

↑ Cellulose

↓

Hamster feeding studies

Turley 1994 [69]

↑ Phytosterols

↓

Human intervention (see table in reference)

↑ Soluble Fibers

↓

Rat and hamster feeding studies

Nguyen 1999 [70]
Feldman 1979 [71]; Schneider 2000
[72]

↑ Ezetimibe

↓

Human and hamster feeding studies

Rosenblum 1998 [73]; Davis 2004 [53]

↑ Sphingomyelin

↓

Mouse feeding studies

Eckhardt 2002 [74]

↓ Bile acid output

↓

Cyp7a1(-/-) mice

Schwarz 2001 [55]

↓ Bile acid/salt pool size

↓

Cyp7a1(-/-) mice

Schwarz 2001 [55]

Factors
(A) Dietary Factors
↑ Cholesterol
Fat

(B) Bile acid factor

↓ Bile acid phospholipid output

↓

Abcb4(-/-) mice

Wang 1998 [54]

↑ Bile acid cholesterol output

↑

Various mouse strains

Wang 2001 [60]

↑ Cholesterol content in bile salts

↑

Various mouse strains

Wang 2001 [60]

↑ Hydrophobic bile salt

↑

Mouse feeding studies

Wang 2003 [57]

↑ Hydrophilic bile salt

↓

Mouse feeding studies

Wang 2003 [57]

↓ ACAT2

↓

Inhibitor in mice
Acat2(-/-) mice

↓ HMG-CoA R

↓

Inhibitor in human and mice

Buhman 2000 [75];
Clark 1984 [76]
Hajri 1995 [77];
Vanhanen 1992 [78]

↓ ABCA1d

↓
↑

Abca1 (-/-) mice

McNeish 2000 [79];
Drobnik 2001 [80]

↓ ABCG5 and ABCG8

↑

↓ NPC1L1

↓

Abcg5/g8(-/-)mice
Npc1/1(-/-) mice
Inhibitor in mice

Yu 2002 [81]
Altmann 2004 [82];
Davis 2004 [53]

↓ SR-BI

(-)

Sr-b1 (-/-) mice

Mardones 2001[83];

↑ SR-BI

↑

Overexpression in CHO cells

Altmann 2002 [84];

↑ SR-BI

↓

Hepatic overexpression in mice

Sehayek 1998 [85]

↓ Caveolin1

(-)

Cav1 (-/-) mice

↓ MTP

↓

Inhibitor in human

↓ APO-B48

↓

ApoB48 (-/-) mice
Apo-B100-only mice

Valasek 2005 [86]
Samaha 2008 [87];
Cuchel 2007 [88]
Young 1995 [89];
Wang 2005 [90]

↑ LXRs

↓

Agonist in human

Repa 2000 [91]

↑ FXR

↓

Agonist in human

Repa 2000 [91]

↑ RXR𝛼

↓

Agonist in mice

Repa 2000 [91]

↑ PPAR𝛼

↓

Ppar𝛼 (-/-) and agonist in mice

Knight 2003 [92]

↑ PPAR𝛿

↓

Agonist in mice

Van Der Veen 2005 [92]

(C) Genetic factors

d

6

Cholesterol
Table 2: Continued.

Factors

Influencing

c

Research method

References
Wang 2004 [59]

(D) Intestinal lumen factor
↑ Small intestine transit time

↑

Cck-1 receptor (-/-) mice

↑ Gastric emptying time

↑

Various of mouse strains

Kirby 2004 [93]

↓
(-)
↓

Muc1 (-/-) mice
Cel (-/-) mice
Cel (-/-) mice

Wang 2004 [59]
Kirby 2002 [94]
Weng 1999 [95]

↓

Ptl (-/-) mice

Huggins 2003 [96]

↓ MUC1
↓ CELd
↓ PTL
a

Table 2 is modified from Wang 2005 [90] with supplement. b Abbreviations: MUFAs, monounsaturated fatty acids; PUFAs, polyunsaturated fatty acids; CYP7a1,
cholesterol 7𝛼-hydroxylase; ABC, ATP-binding cassette (transporter); ACAT2, acyl-CoA:cholesterol acyltransferase, isoform 2; HMG-CoA R, HMG-CoA
reductase; NPC1L1, Niemann-Pick C1-Like 1; SR-BI, scavenger receptor class B member I; MTP, microsomal triglyceride transfer protein; APO, apolipoprotein;
LXR, liver X receptor; FXR, farnesoid X receptor; RXR, retinoid X receptor; PPAR, peroxisomal proliferator activated receptor; CCK, cholecystokinin; MUC,
mucin gene; CEL, carboxyl ester lipase; PTL, pancreatic triglyceride lipase; c ↑ increase, ↓ decrease, (-) no influence. d Contradictory result from different
research groups.

When Abcb4, an ABC transporter gene encoding hepatic
microtubule flinty flippase, was knocked out in mice, the
secretion of bile acid and phospholipids was inhibited. In
homozygous and heterozygous Abcb4-deficient mice, the output of bile acid and phospholipids is important for maintaining normal cholesterol absorption in the small intestine [54].
In cholesterol 7𝛼-hydroxylase gene (Cyp7a1) knockout mice,
bile acid output and bile acid pool size decreased significantly,
as a result of limited absorption of cholesterol due to the
lack of bile acids [55]. Cyp27a1 gene encodes one of the key
enzymes for bile acid synthesis pathways [56]. Therefore, the
Cyp27a1 gene-knockout mice have decreased bile acid pool
size. The intestinal absorption of cholesterol decreased from
54% to 4%, and feces bile acid excretion increased 2.5-fold
in Cyp27a1 knockout mice, while feeding them a bile acidrich diet reversed the impairment of intestinal cholesterol
absorption [56]. These findings demonstrate that both the
size of bile acid pool and the output of bile salts play important
roles in the intestinal absorption of cholesterol [57].
Human and animal experimental studies have found that
short transit time in the small intestine decreases absorption of cholesterol [58]. Cholecystokinin-1 receptor gene
(Cck1) knockout mice showed a higher cholesterol intestinal
absorption efficiency, resulting in the excessive secretion
of bile cholesterol and the formation of cholesterol stones
[59]. However, in the cholesterol congenital fatigue mice, the
intestinal transit time is as important as the length and weight
of the mouse small intestine [60].
The increase of age will lead to significant increase of
intestinal cholesterol absorption efficiency in rodents [61,
62]. Sexual differences will also lead to different cholesterol
absorption efficiency probably due to female hormones. The
secretion of bile lipids (bile salts, phospholipids, and cholesterol), the concentration of cholesterol in bile, the size of the
bile pool, and the hydrophobicity of the bile salt pool increase
significantly with age. The mixture of bile factors has a
significant impact on the absorption of cholesterol efficiency
in the small intestine with the increase of age. In addition,
estrogen can significantly increase the bile flow rate and the
output of bile salts, cholesterol, and phospholipids [63, 64].

3.3. Methods of Measuring Cholesterol Absorption Efficiency in
the Small Intestine. Accurate measure of the small intestinal
cholesterol absorption is essential for the determination of
the dynamic cholesterol homeostasis. In healthy congenital
fatigue mice, the range of cholesterol absorption efficiency
varies widely from 20% to 90% based on the stool double
isotope proportional labeling method [57]. There are direct
and indirect methods to detect intestinal absorption rate
of cholesterol in mice. The direct method is lymphatic
intubation which detects cholesterol transport from the small
intestine to the mesenteric and thoracic lymphatic ducts. This
requires special lymphatic and duodenal cannulas to measure
perfusion of cholesterol [97, 98]. The most common method
is the stool double isotope ratio labeling method. Radiolabeled cholesterol and labeled nonabsorbed phytosterols
used as markers were fed to the subjects [99, 100]. This
method relies mainly on the accurate detection of excretion
and ratio of two isotopes in the stool [57]. The simplest
method for testing of the intestinal cholesterol absorption is
stool and plasma dual plasma isotope labeling method. Both
[3 H] and [14 C]-labeled cholesterol are injected intragastrically and intravenously. The isotope ratio of plasma cholesterol is then periodically measured. Intravenous injection is
assumed as the 100% absorption reference [100]. Sterol balance method is based on measuring the difference between
cholesterol intake and excretion when testing the absorption
of exogenous sterol. The detection of external excretion of
neutral steroid is the key point in this method [57].
Under high cholesterol intake condition, stool and plasma
dual isotope labeling method is not suitable to test the intestinal cholesterol absorption [57]. When the dietary cholesterol intake increases, intestinal absorption of cholesterol
decreases, while the expression of steroid efflux transporters
ABCG5 and ABCG8 are upregulated. In such cases, sterol
balance and the lymphatic intubation methods are good ways,
which detect not only the percentage but also the amount
of cholesterol absorption from the lumen of small intestine
[57]. Applying labeled sitosterol and sitostanol as reference
markers may influence the accuracy of intestinal cholesterol
absorption. Therefore, in animal and human studies, sterol
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Figure 2: The cellular cholesterol partition and key enzymes
of cholesterol metabolism. The cholesterol (C) from low-density
lipoprotein (LDL) could be uptaken by liver cell via two ways, the
endocytosis and hydrolyze LDL via lysosome or digest and uptake
via lipoprotein lipase on the cell membrane. Cholesterol could be
esterified into cholesteryl esters (CE) for storage in liver or be
used for synthesize bile acid or oxysterol via cholesterol 7 alphahydroxylase (CYP7A1) on endoplasmic reticulum (ER) or via sterol
27-hydroxylase (CYP27A) in mitochondria. Cholesterol could also
be synthesized de novo via enzyme on ER.

balance method is an ideal method to test the intestinal
cholesterol absorption.

4. Regulation of Cholesterol Metabolism
4.1. Cholesterol Biosynthesis in the Body. Cholesterol biosynthesis is a complicated 37-step process. These intracellular
steps occur in the cytosol and ER and use acetyl CoA to
make a 30-carbon linear molecule, squalene, which is further
cyclized and modified into the 27-carbon cholesterol [101,
102] (Figure 2). In the cholesterol synthetic pathway, the first
cyclized sterol product derived from squalene is lanosterol
which is catalyzed by oxidosqualene cyclase [101, 103]. The
remaining 19 steps include methyl oxidation, alkene shifting,
and ketone reduction [101, 103]. From the acetyl CoA to
cholesterol, the rate-limiting step of cholesterol synthesis
is catalyzed by hydroxymethylglutaryl-CoA (HMG-CoA)
reductase which is tightly regulated [101, 103].
Majority of the enzymes catalyzing the first phase from
acetyl CoA to lanosterol are membrane proteins located in
the ER inner membrane including HMG-CoA reductase
[104]. Other enzymes in this phase also locate in peroxisome,
such as mevalonate kinase, or in cytosol, such as HMGCoA synthetase [104, 105]. Enzymes converting lanosterol
into cholesterol mainly locate in ER and its extension parts,
nuclear membrane, or lipid droplets [102].
4.2. Cholesterol Homeostasis and Regulation. The intracellular cholesterol level is monitored and regulated by the
proteins on ER membrane. SREBP and LXR are the important
transcriptional factors involved in cholesterol homeostasis
[104–106]. SREBPs increase the transcription of genes encoding proteins in the cholesterol biosynthetic pathway, such as
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HMG-CoA reductase, while LXRs activate the expression of
genes encoding proteins involved in cholesterol metabolism
(Figure 3) [106–108].
The cholesterol level in ER is sensed by a sterol sensing
domain (SSD) composed of five membrane-spanning 𝛼helices, which exist in many cholesterol sensing proteins
[109]. When the cholesterol or lanosterol level is high in the
cell, the SSDs of HMG-CoA reductase and SREBP cleavage
activating protein (SCAP) sense the sterol and cause those
proteins to bind to Insig in the ER membrane [106]. Insig
binding to the HMG-CoA reductase causes it to be degraded,
which reduces the cholesterol synthesis rate [106]. On the
other hand, the binding of Insig to SCAP entrenches the
SREBPs on the ER, which decreases the transcription of genes
for cholesterol synthesis. When the intracellular sterol level is
low, the SSDs of HMG-CoA reductase and SCAP dissociate
and release the Insig on ER. As a result, the reductase will keep
working and produce cholesterol, and SCAP-SREBP complex
will be associated with a coat protein complex II (COPII)
vesicle and be transported to the Golgi where proteases cut
SREBPs and release the active SREBPs. The active SREBPs
enter the nucleus, bind to the SREBP regulatory element
(SRE) and stimulate the transcription of genes such as HMGCoA reductase [101, 109].
LXRs regulate gene expressions in diverse processes of
metabolism [101, 109]. LXR and retinoid X receptor (RXR)
bind to their ligands and form a heterodimer to bind to the
promoter of their targeted genes to regulate their expression,
including genes for sterol metabolism [101, 108]. When sterol
metabolites, which are ligands of LXR, levels are high,
they bind to LXR to regulate genes involved in cholesterol
metabolism and excretion, such as Cyp7a1 which catalyzes
the rate-limiting step of hepatic bile synthesis from cholesterol and ABCG5/G8 which are cholesterol efflux pumps. As a
result, the cholesterol will be used or excreted out of the cell to
decrease its intracellular concentration. However, when those
sterol metabolites levels are low, the lack of ligands for the
activation of LXRs will lead to the reduction of those genes’
expression [101, 108].
Nearly 75% of serum cholesterol in humans is derived
from cholesterol biosynthesis while the rest is derived from
the diet. About 850 mg cholesterol is synthesized by an
average 70-kilogram adult per day. If the person consumes
400 mg/day cholesterol from diet and absorbs 60% [110], that
means only 22% of cholesterol handled in the body comes
from the diet (240 mg from the diet out of a total of 1090 mg).
Lin and Connor reported that consuming diets with high
cholesterol could cause feedback inhibition of cholesterol
biosynthesis and increase of bile acid excretion [111, 112].
Such tiny changes with dietary cholesterol intake and the
tight feedback control can limit its effect on cholesterol
homeostasis in the body. Therefore, a marginal change in
serum cholesterol for most healthy people occurs in response
to the dietary cholesterol level change.
4.3. Cholesterol Esterification and Hydrolysis of CE. The 3 OH group of cholesterol can be esterified into CE which can
be stored in cytosolic lipid droplet or used to form lipoproteins. ACAT catalyzes this esterification reaction and is widely
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Figure 3: Regulation of cholesterol homeostasis via SREBP and HMG-CoA reductase. When the cholesterol (C) or oxysterol level is high,
they can bind to sterol sensing domain (SSD) of the sterol regulatory element binding protein (SREBP) cleavage activating protein (SCAP)
or HMG-CoA reductase. In this case, SREBP will be stabilized on ER to be inactivated, and HMG-CoA reductase will be degraded therefore
cholesterol synthesis will be inhibited. The low cholesterol level causes release of Insig and allows the SCAP/SREBP to enter the COPII coated
vesicle. The vesicle will move to Golgi and the SREBP will be cleaved into the activated form. The mature SREBPs enter into nucleus to bind
to sterol regulatory elements (SREs) to induce the downstream genes expression.

expressed in different types of animal cells [113, 114]. There are
two isoforms of ACAT. ACAT1 catalyzes the esterification and
storage of CE in the lipid droplets in macrophages, whereas
ACAT2 catalyzes the esterification and incorporation of CE
into lipoproteins, such as chylomicrons in the intestinal
epithelial cell and very-low-density lipoprotein in the liver.
ACAT is an integral membrane protein which is mainly
found on ER membrane [113, 114], but, in macrophages, it
is also found near the trans-Golgi network and endocytic
recycling compartment [115]. The esterification of cholesterol
and hydrolysis of CE are in a continuous intracellular cycle.
When the cholesterol level is high, ACAT is activated and
esterifies cholesterol into CE for storage, while when the
cholesterol level is low, neutral cholesteryl ester hydrolases
(nCEHs) catalyze the reverse reaction to release cholesterol
into cells (Figure 2) [116]. nCEHs are also widely expressed in
tissues. The regulation of nCEHs activity is not well known,
and only the nCEH in the liver is thought to be regulated by
the cholesterol flux [116, 117].
4.4. Cholesterol Metabolites. Cholesterol can be converted
into bile acids in the liver or secreted into bile as free cholesterol to be excreted in feces [116, 118]. Therefore, the
cholesterol in extrahepatic tissues needs to be taken into
circulation and transported back to the liver for secretion
[116, 118]. There are two pathways for the conversion of
cholesterol into bile acids: the classic pathway and the
alternative pathway [119]. The rate-limiting enzyme for classic
pathway is CYP7A1 which locates in ER. The enzyme for
the alternative pathway is sterol 27-hydroxylase (CYP27A)
which locates in mitochondria (Figure 2) [116, 120]. Classic
pathway exists specifically in the liver, while the alternative pathway is found in almost all tissues and has been

considered for oxysterols production in extrahepatic tissues
[116]. Oxysterols, derived from cholesterol, can serve as
ligands for the activation of LXRs [108, 116]. Because of
their hydrophilic feature, oxysterols represent another way
to move cholesterol back to liver from other tissues, which
is different from the way via lipoproteins [113, 116]. Steroid
hormone is another class of sterol which is produced from
cholesterol and plays an important role in the growth and
development of animals. There are five classes of steroid
hormones in mammals: glucocorticoids, mineralocorticoids,
progestins, and androgens [121]. Another functional steroid,
neurosteroid, function as neurotransmitters in the brain. The
functions of neurosteroids include regulation of axons’ and
dendrites’ growth, neuroprotection, and myelinization [122].

5. The Relationship between Egg and
Cholesterol Homeostasis
5.1. Effect of Egg Intake on Lipoprotein Metabolism. The potential influence of egg consumption on CVD probably could
be mediated by the influence of egg consumption on lipoprotein level, lipoprotein particle feature, HDL metabolism, and
functionality. Studies have shown that although consuming
eggs often results in the increases of both serum LDL and
HDL levels, the LDL/HDL ratio is unchanged (Table 3).
Therefore, the adverse effect of LDL on CVD might be counteracted by the beneficial effect of HDL. It has been shown
that many other lipoprotein features which correlate to CVD
risks can also be changed by egg consumption [20, 92, 93, 123–
126]. The cholesterol needed by peripheral tissues including
blood vessels can be transported by LDL, and when LDL
level is too high, it accumulates in the artery wall, causing
inflammation and oxidation [127]. This leads to uptake of
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cholesterol by the foam cells, resulting in endothelial damage
and the occurrence and development of atherosclerosis. HDL
removes the cholesterol from the foam cells to inhibit LDL
oxidation, attenuate inflammation, and reduce the transport
of cholesterol to prevent atherosclerosis, and HDL also has
the characteristics of being antithrombotic [127].
The serum lipid responses to dietary cholesterol were
tested by Berger et al. [128] across 19 intervention trials.
Serum LDL-Cholesterol (LDL-C) (6.7 mg/dL net change)
and HDL-C (3.2 mg/dL net change) are greatly increased
by dietary cholesterol intake, mostly from eggs, with a
marginal increase in the LDL-C/HDL-C ratio (0.17 net
change) [128]. The ratio of LDL-C/HDL-C can be used to
estimate the likelihood of forming plaque in blood vessels,
and therefore it can be used as an indicator of CVD risk
[129]. LDL-C/HDL-C ratio <2.5 is considered to be the cutpoint of personal lipoprotein recommendations, and there
is evidence that, in some people above this level, the risk
of cardiovascular events is higher [129, 130]. Other studies
in children and adults with normal cholesterol levels also
reported the significant increase of LDL-C and HDL-C with
2-4 eggs’ intake per day comparing to without egg yolk, while
the LDL-C/HDL-C ratio did not change [92, 123, 124, 131].
Although Herron reported an increase of LDL-C/HDL-C
ratio consuming 3 eggs per day for 30 days in healthy men
who were classified as hyperresponders (increase in total
cholesterol of ≥0.06 mmol/L for each additional 100 mg of
dietary cholesterol consumed), the average ratio (2.33±0.80)
was still in the normal range of <2.5 [126]. In adults with
high cholesterol, eating two eggs per day could lead to
higher HDL-C without a change in LDL-C, while both the
HDL-C and LDL-C increased in adults with hyperlipidemia
(elevated serum cholesterol and triglyceride) [132]. In the
elderly who took statins, two or four eggs per day did not
significantly increase LDL-C, while HDL-C was increased
with both doses of eggs [133]. And consumption of eggs might
have contributed to the conversion of LDL from pattern
B particles into pattern A in the human body, and the
pattern A LDL particles have large size and are easy to float,
which reduces their potential to stimulate the development of
atherosclerosis [123].
Although LDL-C and HDL-C levels are related to CVD
risk, some features of lipoproteins may also affect disease risk,
such as particle characteristics, particle size, and composition. For example, higher plasma concentrations of large HDL
subclass particles are strongly positively correlated to CVD
risk, while the correlations between the lower level of small
HDL particles and the risk of CVD are weak [134, 135]. However, higher plasma concentrations of small LDL particles are
highly related to CVD development, explained by its higher
oxidation susceptibility than larger LDL particles [135, 136].
Oxidized LDL is a major driver of plaque formation, which
results in atherosclerosis and CVD [137].
HDL is believed to play a protective role in atherosclerosis
through its role in reverse cholesterol transport (RCT),
as well as its antioxidant and anti-inflammatory activities
[138]. Dietary cholesterol feeding in mice has been proved
to induce RCT by compensatory induction through HDL
related pathways [139]. With the intake of cholesterol and/or
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eggs in diet, it is not clear whether the increase of HDL-C
level and particle size would result in increasing of RCT in
human. Several drug trials have failed to show the benefits
of improving HDL-C on CVD [140, 141]. However, studies
have shown that dietary cholesterol and/or eggs may affect the
function of HDL other than modifying HDL-C level. Dietary
cholesterol intake independently predicts the activity of
serum paraoxonase-1 (PON1) arylesterase in a human study
[142]. PON1 is a lipolactonase carried by HDL, which may
protect atherosclerosis by preventing lipoprotein oxidation,
inhibiting macrophage inflammation, and enhancing cellular
cholesterol outflow mediated by HDL [143]. Interestingly,
the serum PON1 arylesterase activity of young and healthy
adults increased significantly after eating 3 eggs per day for
4 weeks. In addition, with egg intake, the increase in large
HDL particle concentration is consistent with the increase
in lecithin cholesterol acyltransferase (LCAT) activity [18].
LCAT is a HDL-associated enzyme which is critical to promote the maturation of HDL by esterifying free cholesterol
into cholesterol esters. Macrophages mobilization through
HDL-C, known as cholesterol efflux, have shown in cohort
studies that they can be used to predict the cause of CVD,
independent of HDL-C level [144, 145]. It is worth noting
that when adults with metabolic syndrome eat three eggs
per day for 12 weeks, serum cholesterol excretion increases
[145]. Generally speaking, in addition to increasing HDL-C,
dietary cholesterol can also improve other indicators of HDL
function. However, more investigation of the effect of dietary
cholesterol on human HDL function is justified.
5.2. The Effects of Egg Components on Cholesterol Homeostasis.
There are some nutrients in egg, such as ovomucin [146],
sulfur-containing proteins [147–149], hydrolyzed proteins
[106], and phospholipids [43], which may be considered
bioactive and have their own functions. Those components
may regulate cholesterol absorption and metabolism, which
counteracts the adverse effects of high dietary cholesterol
intake [150, 151]. However, which bioactive components
would regulate the cholesterol metabolism and how they
work remain to be studied. This argues the potential difference of effect of consuming pure cholesterol and the whole
egg on the risk of CVD. Components other than cholesterol
in egg may be bioactive and impact on cholesterol absorption,
metabolism, transportation, and excretion.
5.2.1. Protein and Amino Acids in Eggs. Eggs contain proteins
that provide all essential amino acids for human nutrition.
Individual amino acids such as glycine (Gly), glutamate (Glu),
methionine (Met), and cysteine (Cys) in eggs play roles in
regulating cholesterol metabolism. Met can participate in
the formation of phospholipids, which are needed for the
formation of lipoproteins. Glu, Cys, and Gly are used to
synthesize glutathione, an activator of CYP7A1, which is
critical for bile acid synthesis. In addition, Gly and Cys are
involved in the formation of taurine, which is conjugated to
bile acids [152].
Egg ovomucin attenuates hypercholesterolemia in rats
and inhibits cholesterol absorption in Caco-2 cells [153].
The interplay of the cholesterol-containing micelles and
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the small intestinal epithelial cells inhibits the absorption
of cholesterol and may be part of the cholesterol-lowering
mechanism. Egg ovomucin may also inhibit the reabsorption
of bile acids in the ileum, thereby lowering serum cholesterol
levels [153]. Sulfur-containing proteins have been thought to
increase HDL, decrease LDL, and attenuate atherosclerosis
and metabolic syndrome. These proteins may affect lipid
metabolism through modifications of transcriptional factors
[147–149]. Manso et al. have shown in animal feeding and in
vitro experiments that proteins from hydrolyzed total eggs
can inhibit the absorption of cholesterol and may also affect
the cholesterol metabolism in vivo [106]. A recent study
suggested that the consumption of egg white in mice showed
no significant changes in total cholesterol, HDL, LDL, or TG
levels [154].
5.2.2. Fatty Acids in Egg Yolk. Egg yolk contains abundant
unsaturated fatty acids, which account for nearly two-thirds
of the total lipids as shown in Table 1. These include n3 PUFAs that are absorbed with cholesterol upon food
intake. They may affect cholesterol uptake and plasma LDLcholesterol level [155]. It seems that, compared with other
cholesterol-rich foods such as meat, eggs have some unique
characteristics. Fang et al. evaluated the effects of six fatty
acids: palmitic acid, oleic acid, linoleic acid, arachidonic
acid, EPA, and DHA on cholesterol uptake and transport in
human enterocytes Caco-2 cells and on the mRNA expression
levels of NPC1L1 and other proteins involved in cholesterol
absorption. The results showed that EPA and DHA dosedependently inhibited cholesterol uptake and transport in
Caco-2 monolayer, which might be caused by downregulating NPC1L1 mRNA and protein levels [45].
An egg yolk contains nearly 331 𝜇g carotenoids lutein
and zeaxanthin. Fernández-Robredo et al. have studied the
influence of egg yolk and the protective effect of lutein
supplement on the structural deterioration of retina in the
apolipoprotein E deficient (apoE -/-) mice. The ingestion
of egg yolk reduced the plasma TG level whereas total
cholesterol remained constant, indicating its potential to
reduce the risk of heart diseases [146].
5.2.3. Phospholipids in Egg Yolk. Phospholipids are a major
component of eggs as shown in Table 1. As a major component, phospholipids account for ∼10% of the wet weight of
egg yolk [42], which mainly contains PC (80.5%), PE (11.7%),
lysoPC, SM, and some neutral lipids in minor quantities.
Alfred Rampone reported that excess phospholipids could
inhibit intestinal cholesterol uptake [156–158]. Then Rodgers
and O’Connor hypothesized that lysoPC hydrolyzed from
PC could lead to rapid uptake of cholesterol and attenuate
the inhibitory effects of PC [159]. Microcapsules containing
PC can reduce the absorption of cholesterol, esterification,
and secretion. When half or more than half of the PC
content in micelles is replaced by lysoPC, this inhibitory effect
disappears [160]. Recently, in vitro studies using intestinal
segments [161] or intestinal cell lines [74, 162] showed that
phospholipids could alter the rates of micellar formation
and diffusion to inhibit the intestinal uptake of cholesterol.
In vivo studies have confirmed that native phospholipids
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exert an inhibitory effect on intestinal cholesterol absorption
[61, 97, 163–166]. Recently, Fang et al. confirmed that the
phospholipids PC and SM from egg yolk, which are considered as functional food ingredients, significantly inhibit the
intestinal absorption of cholesterol in the Caco-2 monolayer
[44]. Therefore, consuming eggs may inhibit the intestinal
absorption of cholesterol via the phospholipids in eggs. A
fundamental question is how this biological effect is regulated. Three possible mechanisms may be responsible for the
inhibitory effect of excessive phospholipids on the intestinal
absorption of cholesterol.
Firstly, the excessive intake of phospholipids interferes
with its hydrolysis in micelles, which can promote cholesterol
absorption [167]. Recent evidence showed the key role of
phospholipase A2 (PLA2), a pancreatic secreted enzyme,
in cholesterol absorption. The phospholipid composition
in micelles and the effect of PLA2 on lipid uptake and
metabolism have been demonstrated in human intestinal
caco-2 cells [161]. The inhibitory effects of phospholipids
on cholesterol absorption can be attenuated when PLA2 is
added. Anti-PLA2 antibody has been shown to completely
inhibit the action of the extracts from pig pancreas and inhibit
the absorption of cholesterol optimization in Caco-2 cells
[160]. PLA2 inhibitors (FPL67047XX) also have been shown
to block cholesterol absorption [168]. All these indicate that
small intestinal absorption of micellar cholesterol depends
on the hydrolysis of phospholipids in micelles, and inhibition of the hydrolysis of phospholipids directly interferes
with cholesterol intake. Therefore, elevated consumption of
phospholipids may hinder or delay phospholipid hydrolysis
in normal micelles and affect downstream cholesterol absorption.
The second kind of inference mechanism is that excess
phospholipids affect the physical and chemical properties
of micelles containing cholesterol (such as their size, composition, and biological properties). The phospholipids can
cause cholesterol molecules from micellar phase into a
lamellar (blister phase) which is difficult to be absorbed [169].
After chyme enters the duodenum from the stomach, the
bile acids and lipids are present in different physical states
(simple micelles, mixed micelles, and vesicles). The process
of lipid hydrolysis by pancreatic enzymes, the accumulation
of hydrolytic products, and the action of bile acids would
transform the vesicles’ shape and properties, which is necessary for lipid absorption. It can be speculated that excessive
phospholipids may hinder the vesicle transformation, and
phospholipids from different dietary sources can change the
solubility of micelle, thereby preventing cholesterol to be
absorbed by the small intestinal mucosa [169]. A study by
Martin Carey’s laboratory found that the degree of unsaturation of fatty acyl chains in phospholipids regulates the
distribution of PC in micelles and the vesicles [170, 171].
The cholesterol solubility in the system of SM or saturated
2-palmitoylcholine is extremely poor [74]. Compared with
eggs, the SM in milk, which contains fatty acids with higher
saturation and longer chain length, can inhibit the absorption
of cholesterol more effectively [98]. This indicates that the
intestinal lumen phospholipid content and types will affect
the physicochemical properties of intestinal micromicelles
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and, in turn, the absorption and metabolism of cholesterol.
The third inference mechanism involves the direct effect
of phospholipids on cholesterol absorption in small intestine
epithelial cells. It can be speculated that phospholipids in
the intestinal lumen may affect cell membrane properties
or directly affect intracellular cholesterol transport, thereby
affecting intestinal cholesterol absorption. Fang et al. recently
stated that egg yolk PC and SM could dose-dependently
inhibit cholesterol uptake and transport in Caco-2 monolayer by regulating some intestinal cholesterol transport
proteins and transcriptional factors [44]. SM downregulate
the NPC1L1 expression levels in Caco-2 cells. Although few
data could support this inference mechanism, it is well known
that the biological function of the cell membrane highly
depends on the phospholipid components and the interplay
of the intramural cholesterol [172]. In addition, membrane
protein activity can be directly influenced by its interaction
with the membrane [173]. Therefore, dietary phospholipids
may directly affect the uptake of cholesterol in the intestinal
epithelium.
On the other hand, recent studies of gut microbiota show
a different story. PC, like carnitine from red meat, is converted
by intestinal bacteria into trimethylamine. Trimethylamine
is oxidized in the liver to trimethylamine N-oxide (TMAO),
and TMAO increases in a dose-dependent manner with egg
consumption [174]. TMAO causes atherosclerosis in animal
models [175] and in human subjects accelerates decline of
impaired renal function [176] and increases cardiovascular
risk [176, 177].
5.2.4. Other Factors. Besides the common macronutrients,
eggs are rich in glycine betaine, mercaptan, sialic acid,
vitamins, and minerals; they might directly affect human
body blood vessel functions or cholesterol metabolism by
regulating activities of related enzymes or indirectly affect
blood lipid level by regulating protein, fat, and carbohydrate
metabolism. For example, Cys and glutathione may help to
remove free radicals. Egg contains vitamins A, E, B2, and
B6 and vitamin B12, which are able to resist LDL oxidation,
lower homocysteine accumulation, dilate blood vessels, and
prevent the happening of the angina pectoris, atherosclerosis,
and myocardial infarction [85]. There are more than 40 kinds
of trace elements in egg. They may play a vital role in the
structure and function of cell membrane, lipid metabolism
and stability, the contraction diastole heart, regulating blood
pressure and blood coagulation and catalytisis, and inhibiting
free radicals [85]. The ratio of LDL and HDL in egg is the
same as that in human blood and LDL maintains pattern
conversion. Despite the existence of cholesterol in the egg
yolk, its impact on CVD may be different from the cholesterol
in other food sources such as meat. In addition, when
cholesterol is increased from food, the body makes less
in healthy individuals. When the body’s daily intake of
cholesterol reaches more than 2 g, the absorption rate will
gradually decrease, the synthesis of cholesterol in the body
is reduced, and the neutral cholesterol content in the stool
increases. If the cholesterol intake is low, cholesterol synthesis
will increase to maintain a constant value [178].
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6. The Relationship between Egg Intake and
CVD Risks
6.1. Half-Century Debate of the Relationship between Dietary
Cholesterol Intake and CVD Risks. Total body cholesterol is
balanced via absorption from diet, biosynthesis in the body,
and excretion out of the body [122]. In the 20th century,
the dietary cholesterol and heart diseases hypothesis was
proposed by the famous Framingham Heart Study, which
reported the relationship between blood cholesterol and
heart disease [3, 4]. This diet-heart disease hypothesis states
that there is a causal relationship between dietary saturated
fat and cholesterol intake and the serum cholesterol level,
as a result increasing the risk of CVD [82]. According to
this hypothesis, limiting the dietary cholesterol intake was
advocated by animal studies [8, 179], observational studies [8,
12, 180, 181], and some dietary guidelines [8, 182]. In 1968, the
AHA recommended that the dietary cholesterol consumption
should be no more than 300 mg/day and emphasized no more
than 3 egg yolks should be consumed per week [8].
Weggemans et al. [180] conducted meta-analysis of the
epidemiologic studies to determine the relationship between
dietary cholesterol intake and serum cholesterol level. Seventeen studies taken between 1979 and 1999 are included in
this analysis. Fifteen studies observed an increase of total
serum cholesterol level, 14 studies observed an increase of
serum LDL, and 8 studies observed an increase of serum
HDL, with the increasing of dietary cholesterol intake. They
found that dietary cholesterol intake would increase the ratio
of total to HDL cholesterol level, and with the addition of
100 mg dietary cholesterol intake per day, this ratio would
increase by 0.020 units. Although both serum total and HDL
cholesterol were increased, the increase of the ratio of total to
HDL cholesterol indicates an overall adverse effect of dietary
cholesterol intake on the serum cholesterol profile, which
supports the diet-heart disease hypothesis [180]. Also, serum
cholesterol predictive equations proposed by Keys (1965)
and Hegsted (1993) included dietary cholesterol intake as
a positive factor in addition to dietary saturated fatty acid
intake [183, 184].
The average intake of dietary cholesterol in US adults
ranges from 200 to 350 mg/day due to sex and age differences
[9], which is quite close to the recommended consumption
limitation by AHA [8]. Daily intake of eggs and egg products
accounts for a quarter of daily cholesterol intake in US
children and adults [10, 11]. Therefore, people tend to limit
their consumption of eggs to decrease the cholesterol intake,
in order to protect themselves from CVD. However, the
controversy does not stop here, later studies do not support
this hypothesis, and potential beneficial effects of egg on CVD
have been reported [12–23, 150, 151, 185]. A prospective study
with over 117,000 adults and 14-year follow-up demonstrated
that there were no differences of CVD risks between participants that consumed one egg per week and those who
consumed one egg per day [12]. Studies also found that eating
large amount of eggs (10 eggs/day) does not significantly
influence the serum cholesterol level comparing to the low
intake (1 egg/day), and some even found there is a negative
correlation [185]. Besides, egg consumption is not related to
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the incidence of CVD [15, 47, 186]. Whether the effect of
egg yolk is worse than other dietary cholesterol resources
on serum cholesterol level is still controversial [150, 151].
Therefore, some researchers recommended consuming egg
to healthy people unless they are allergic or intolerant to
egg, based on their findings that eggs are good resources for
other nutrients. With increasing evidences, AHA eliminated
the restriction of egg consumption in 2002, and the dietary
restriction of cholesterol for healthy population in 2013 [24].
Eventually, in 2015, DGAC also eliminated this restriction
from the latest version of dietary guideline [25]. However,
comparing with other types of diet such as the Mediterranean
one, Western diet in USA contains much more risk factors
of CVD other than dietary cholesterol intake. Therefore, the
adverse effect of dietary cholesterol might be shadowed by
other risk factors [187]. Also noted is that the marginal relationship between dietary cholesterol intake and CVD risks
is reported only in healthy people. Many studied reported
doubling or even 5-fold increase of coronary disease risk as
a result of an egg per day in diabetic participants [12, 13, 126].
6.2. Effect of Egg Intake on Blood Cholesterol and CVD in Animal Studies. Studies in animal models show that the impact
of egg intake on blood cholesterol is minor. FernándezRobredo gavaged apoE−/− mice, a hypercholesterolemia and
CVD model, with two egg yolks per day. The supplement
of egg yolk in this amount did not increase the serum
cholesterol; instead, the serum TG and lipid peroxidation
were decreased [146]. Yang’s study in Sprague-Dawley (SD)
rats fed egg-enriched and high cholesterol diet observed
decreased serum total cholesterol and increased HDL [188].
Egg-enriched diet increased the fecal excretion of sterols and
bile acids, enhanced the HDL-reverse cholesterol transport
and cholesterol hydroxylation indicated by elevated expression levels of CYP7A1, LCAT, and ACAT, and decreased the
cholesterol biosynthesis in the presence of reduced expression
of hepatic HMG-CoA reductase [188]. They speculated that
some compounds such as phospholipids and certain protein
could decrease the absorption of cholesterol in the intestine
[146, 153].
Jiang et al. infused SD rats through lymph cannula with
the lipid emulsion containing 14 C-cholesterol and PC from
different sources (egg PC, hydrogenated egg PC, and soy PC)
[97]. The egg PC dramatically decreased the absorption of
cholesterol, comparing to soy PC. This difference could be
explained by the higher saturation of acyl groups in egg PC
in comparison with that from soy [97]. This result indicates
that the egg PC may also inhibit the intestinal absorption
of cholesterol, a conclusion that is consistent with that of
Rampone [156]. Other than PC, SM has also been discovered
to inhibit the intestinal absorption of cholesterol in a dosedependent manner, and this effect is achieved by decreasing
the cholesterol monomers’ thermodynamic activity [74, 189,
190]. Noh and Koo compared the inhibitory effects of SM
from different sources, milk and egg, on cholesterol absorption, and found that milk SM had a stronger inhibitory effect
probably due to higher saturation degree and longer chain
of fatty acyl group in SM [98]. Feng found that ceramide,
the hydrolytic product of SM, had a stronger inhibitory
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effect on cholesterol uptake in intestinal cells [191]. The
possible mechanisms of inhibitory effect of phospholipids are
discussed in Section 5.2.
Nagaoka investigated the effect of ovomucin, a major
protein in egg, on the cholesterol metabolism both in vivo
(Wistar rats) and in vitro (Caco-2 cells, a small intestinal enterocyte model) [153, 192]. They found that feeding rats with
ovomucin decreased the serum total cholesterol level and the
total lipids level in the liver [153]. In vivo study showed that the
fecal excretion of bile acids and cholesterol was significantly
increased in rats fed ovomucin in comparison with those fed
casein [153]. Other investigations on the effect of total egg
white protein (EWP) on cholesterol metabolism also showed
some beneficial outcomes. Matsuoka fed SD rats with EWP
and observed the decreased cholesterol level in the serum,
liver, and intestinal mucosa [193]. Both the fecal excretions
of sterols and bile acids were increased, and the cholesterol
micellar formation was interfered, which probably was due
to the reduced cholesterol absorption in rats fed EWP [193].
In another study, spontaneously hypertensive rats were fed
the pepsin hydrolyzed egg white (hEWP) and showed that
the serum total cholesterol was decreased without changing
HDL [163]. A research in human females with moderate
hypercholesterolemia also observed the beneficial effects of
EWP, which included a decrease of serum total cholesterol
and increase of HDL compared to the group fed with tofu or
cheese as the protein resource [162].
All those results in animals showed the potential beneficial effects of egg on blood cholesterol level through
decreasing the absorption and increasing excretion, and several functional compounds were proposed. However, more
experiments through feeding animals with egg yolk and monitoring CVD related indictors other than blood cholesterol
are required to determine the effect of consuming eggs on
CVD risks in animals. Also, other functional compounds
may not have been screened out yet, and the molecular
mechanisms of function remain to be studied in depth.
6.3. Effect of Egg Intake on Blood Cholesterol and CVD in
Human Studies. The effects of egg intake on blood cholesterol
and CVD have been discussed in several meta-analysis
studies using research data collected over 60 years [15, 21–23,
180, 194]. Large epidemiological works have been conducted
to investigate the effect of egg intake on blood cholesterol
levels and risk of CVD in children [123], young people
[16, 20, 47, 124], women [12–14, 125, 195, 196], men [12–
14, 125, 195–199], and older adults [12–14, 125, 195–200]. Some
have shown that egg consumption did influence the blood
cholesterol level but did not increase the risk of CVD in
healthy people. Meanwhile, other studies reported that high
dietary cholesterol intake due to egg consumption is a risk
factor for CVD and diabetes [180, 194, 197, 199, 201–204]. The
results of epidemiological studies and human intervention
studies on the relationship of dietary egg intake and CVD
risks are summarized in Table 3. Even though AHA and
DGAC have removed the restriction of dietary cholesterol for
healthy people in USA, there still are different conclusions
due to differences in race, genetic makeup, physical fitness,
and especially physiological status.
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Goldberg 2014 [206]

Haring 2014 [207]
Houston 2011 [208]
Hu
1999 [12]
Mann
1997 [209]
Nakamura 2004 [195]
Nakamura 2006 [14]
Qureshi 2006 [13]
Sauvaget 2003 [210]
Scrafford 2011 [196]
Zazpe
2011 [45]
Voutilainen 2013 [198]
Pang
2017 [211]

21,327

80,082
6,700

4,077
47,416
5,978
24,999
14,946
8,015
0
8,463

37,851

4,102

5,186
43,319
3,756
15,350

6,170

1,019

8,131

857

0

1077

12,066

912

864

256

258

Participants
Male
Female
43,150
84,010

Bernstein 2011 [178]
Burke
2007 [205]
Dawber 1982 [185]
Djoussé 2008 [197]

Reference

18.8
N/A

>60

5.8

14
10.2
15.9
16
8.8

13.3

14

22
9

11

24
20

14

26

Follow-up (years)

51.9 (Mean)

20-90

30-70
40-69
25-74
34-103
>17

16-79

34-75

45-64
70-79

57-75

30-59
40-85

15-88

30-75

Age

CHD, mortality

Incident stroke

Outcome

Serum LDL and total cholesterol

Carotid atherosclerosis, incident MI

Incident CVD

Stroke and CHD mortality
Incident CHD
All stroke, CAD
Stroke mortality
CHD and Stroke mortality

Ischemic heart disease mortality

Incident stroke and CHD

Incident CHD and blood cholesterol level
Incident MI and stroke
Mortality
Incident stroke
Carotid atherosclerosis
Incident CHD
Incident CVD

(a) Prospective studies

(-)
(-)
↑
(-)
↓
(-)
↑ especially in diabetic people

↑

(-)

Resultb

↑

(-)

(-)

↑ in women
(-)
(-) while in diabetic people may have ↑ effect
(-)
(-)

↑

(-) while in diabetic people may have ↑ effect

Table 3: Epidemiological and human intervention studies on the effect of dietary egg intake and CVD risks.a

Cholesterol
13

51

0

0

29

29
119

45

0

40

28

13

Herron 2003 [126]

Mutungi 2008 [199]

Greene 2005 [200]

Ballesteros 2004 [123] 25
Knopp 2003 [132]
78

86

Herron 2002 [125]

Knopp 1997 [131]

14

16

Lemos 2018 [20]

12

41-68 (HC or HL)

11c

>60
11
4

12

40-70
(overweight/obese)

8-12
43-67

1 egg/day vs.
0 egg/day

11c

18-57

c

1 egg/day vs.
0 egg/day

11c

18-49 (pre-menopausal)

2 eggs/day vs. SUB

2 eggs/day vs. SUB
0, 2 and 4 eggs/day

3 eggs/day vs. SUB

CRD:
3 eggs/day vs. SUB

3 eggs/day vs. choline
bitartrate supplement

13

2 eggs/day vs. oatmeal

11c

18-30

Serum LDL and HDL
Serum LDL/HDL
Serum ghrelin
Serum LDL and HDL
Serum LDL/HDL
SREBPs and HMG-CoA
reductase level
Serum LDL and HDL
Serum LDL/HDL
CETP level
Serum LDL and HDL
Serum LDL/HDL
CETP, LCAT level
Serum LDL/HDL
Serum HDL
Serum LDL and HDL
Serum LDL/HDL
Serum LDL/HDL
Serum LDL and HDL
Serum LDL
Serum HDL

Outcome

↑
(-)
↑ satiety
↑
(-)

Resulta

↑
(-)
↑ reverse cholesterol transport
↑
↑ only in hyper-respondersd
↑ reverse cholesterol transport
(-)
↑
↑
(-)
(-)
↑
↑ in HC
↑ in both HL and HC

↑

↑

Resultb

↓ cholesterol biosynthesis

Mortality

Carotid plaque area

Outcome

Abbreviations: CHD, coronary heart disease; CVD, cardiovascular disease; MI, myocardial infarction; LDL, low-density lipoprotein; HDL, high-density lipoprotein; SREBP, sterol regulatory element-binding
protein; CETP, cholesteryl ester transfer protein; LCAT, lecithin-cholesterol acyltransferase; CRD, Carbohydrate-restricted diets; SUB, cholesterol-free, fat-free egg substitute; HC, hypercholesterolemia; HL,
hyperlipidemia; b ↑ increase, ↓ decrease, (-) no influence. c Intervention time contain a 3-weeks washout time within the intervention period; d hyperresponders: increase in total cholesterol of ≥0.06 mmol/L
for each additional 100 mg of dietary cholesterol consumed.

a

26

24

Intervention method

4.5 (mean)

N/A

Follow-up (years)

Intervention time
(weeks)

(b) Human intervention

50-80 (Adult diabetics)

46-77

Age

Age

589

Participants
Female
593

18-20

424

Male
669

Participants
Male Female

Missimer 2017 [124]

Reference

Spence 2012 [212]
Trichopoulou 2006
[126]

Reference

(a) Continued.
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Cholesterol

Cholesterol
Among the 19 prospective studies investigating the effect
of dietary egg intake on CVD risks, 6 studies reported positive
correlation between egg consumption and different types of
CVD incidents or mortality in healthy people [126, 195, 197,
205, 208, 209]. Pang (2017) reported the positive correlation
with total cholesterol [211], and Spence (2012) reported the
positive correlation with plaque area [212]. However, other
studies (11 out of 19) reported no difference on the CVD
risks affected by the amount of egg intake. The adverse effect
of egg consumption is observed in population with high
risk of CVD, including people with diabetes or hypercholesterolemia, and who are sensitive to dietary cholesterol [12, 13,
126, 131, 210, 213]. Diabetic populations are in the high risk of
CVD with two to four folds higher than healthy people. These
studies also showed that diabetic people are more vulnerable
to CVD after egg consumption [13, 208], with a doubling of
coronary risk with an egg per day in US population [12, 13],
and 5-fold risk in Greece population [213]. Meanwhile, some
studies found that high egg consumption increased the risk
of gestational diabetes mellitus [214], insulin resistance [215],
and the risk of diabetes [202–204]. Therefore, the effect of egg
consumption on CVD might be mediated by diabetes.
Almost all human intervention studies showed the serum
LDL and HDL cholesterol levels increased in high egg
consuming groups (1 to 3 eggs per day comparing to no
egg or with egg substitute), while the ratio of serum LDL
to HDL (LDL/HDL) is unchanged (Table 3). Most of these
papers concluded that egg consumption is not a risk factor for
CVD, based on the fact that the LDL/HDL ratio is unchanged
because this ratio is thought to be a stronger risk factor
for CVD. However, serum LDL level alone should still be
considered as a risk factor for CVD. This is especially true for
those people whose blood cholesterol level is more sensitive
to dietary cholesterol consumption. There are good reasons
for the recommendation that persons at risk of vascular
disease limit cholesterol to 200 mg/day [186]. The very high
cholesterol content of egg yolk (237 mg in a 65-gram egg)
is a problem in itself, and even one large egg yolk exceeds
that limit. Other studies reported the high cholesterol and
high lipid diet could induce the inflammation in plasma,
which is thought to contribute to atherosclerosis [216], and
the susceptibility of LDL to be oxidized could be increased by
dietary cholesterol [217].

7. Outlook
Interestingly, current studies have tended to show that the
consumption of eggs is not a risk factor of CVD in healthy
people. However, people who are at high risk of CVD such as
those with diabetes or hypertension need to have caution with
dietary cholesterol intake, especially egg intake. Also, some
people seem to be more sensitive to dietary cholesterol whose
blood cholesterol level is highly correlated to dietary intake.
Therefore, even though the recommendation of restricting
cholesterol and egg consumption in AHA and DGAC has
been eliminated, we still need to have caution with them
based on the physiological status of people. On the other
hand, the studies on the egg components impacting CVD risk
showed that some egg components have potential protective
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effects on CVD, while others may have adverse effects.
Due to the lack of complete data, the components of eggs
that regulate cholesterol absorption and metabolism have
not been extensively studied systematically. To solve the
mystery of the relationship between egg cholesterol and blood
cholesterol, it is essential to understand intestinal absorption
of cholesterol from eggs and study the effect of cholesterol
in eggs, and nutrients and cholesterol interactions in eggs.
Also, the function of gut microbiota needs to be taken into
consideration as well. Overall, in order to strengthen the
basic research of egg functional components, understanding
of the nutritional value of eggs can provide theoretical data
for reasonable determination of the intake of eggs.
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